financetom
Business
financetom
/
Business
/
Caterpillar's Q4 Adjusted Earnings, Revenue Decrease
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Caterpillar's Q4 Adjusted Earnings, Revenue Decrease
Jan 30, 2025 4:11 AM

06:51 AM EST, 01/30/2025 (MT Newswires) -- Caterpillar ( CAT ) reported Q4 adjusted earnings Thursday of $5.14 per share, down from $5.23 a year earlier.

Analysts surveyed by FactSet expected $5.02.

Revenue for the quarter ended Dec. 31 was $16.22 billion, down from $17.07 billion a year earlier.

Analysts surveyed by FactSet expected $16.61 billion.

Caterpillar ( CAT ) shares were down more than 3% in recent premarket trading.

Price: 379.95, Change: -13.28, Percent Change: -3.38

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Factbox-Corporate America pledges donations for Trump's inauguration
Factbox-Corporate America pledges donations for Trump's inauguration
Jan 9, 2025
(Reuters) -Big companies from Wall Street to Silicon Valley are pledging donations to Donald Trump's inaugural fund before his Jan. 20 return to the White House, hoping to establish a positive rapport with his new administration. The companies include: ALPHABET Alphabet's Google has donated $1 million, a company spokesperson said. AMAZON.COM Amazon is donating $1 million. The company will broadcast...
PureTech Health Gets US FDA Fast Track Designation for LYT-200 to Treat Acute Myeloid Leukemia
PureTech Health Gets US FDA Fast Track Designation for LYT-200 to Treat Acute Myeloid Leukemia
Jan 9, 2025
11:57 AM EST, 01/09/2025 (MT Newswires) -- PureTech Health ( PRTC ) said Thursday the US Food and Drug Administration has given fast track designation to LYT-200 to treat acute myeloid leukemia. The label was designed to expedite the assessment of drugs for serious diseases with unmet medical need, the company said. The regulator previously granted orphan drug designation to...
Airbus keeps top spot with 766 jet deliveries in 2024
Airbus keeps top spot with 766 jet deliveries in 2024
Jan 9, 2025
PARIS, Jan 9 (Reuters) - Airbus delivered 766 airliners in 2024 and looked certain to maintain leadership of the jetmaking industry for a sixth year as arch-rival Boeing ( BA ) recovers cautiously from a prolonged internal crisis, company data showed on Thursday. The European planemaker fell fractionally short of a headline target of around 770 jets but was expected...
Diageo's Challenges Posed by GLP-1 Weight-Loss Drugs Cited by Fundsmith Manager for Selling Stake
Diageo's Challenges Posed by GLP-1 Weight-Loss Drugs Cited by Fundsmith Manager for Selling Stake
Jan 9, 2025
12:02 PM EST, 01/09/2025 (MT Newswires) -- Diageo ( DEO ) shares were on the chopping block for UK fund manager Terry Smith during 2024, with the veteran investor questioning whether the spirits and brewery company will be up to the potential challenge posed by GLP-1 weight-loss drugs on alcohol producers. In his annual message to Fundsmith clients, Smith this...
Copyright 2023-2026 - www.financetom.com All Rights Reserved